Discontinuation report TEVA-LOSARTAN/HCTZ

Last updated on 2021-02-12 History
Report ID 133902
Drug Identification Number 02358263
Brand name TEVA-LOSARTAN/HCTZ
Common or Proper name LOSARTAN/HCTZ 50/12.5MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE
Strength(s) 50.0MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size PP 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-02-05
Remaining supply date 2021-02-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Item is disc
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-12 French Compare
v1 2021-02-12 English Compare